A detailed history of Acadian Asset Management LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,359 shares of EOLS stock, worth $26,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,359
Holding current value
$26,774
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.66 - $17.48 $25,146 - $41,235
2,359 New
2,359 $38,000
Q4 2021

Feb 10, 2022

SELL
$5.37 - $8.38 $223,526 - $348,817
-41,625 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$7.36 - $13.67 $306,360 - $569,013
41,625 New
41,625 $317,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $637M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.